Stock Events

Stock Events

Accelerate Diagnostics 

$0.03
16
-$0.05-61.36% Wednesday 20:00

Statistics

Day High
0.03
Day Low
0.03
52W High
2.09
52W Low
0.01
Volume
13,827,084
Avg. Volume
1,827,821
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

7AugExpected
Q4 0
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-13.74
-11.37
-9
-6.63
Expected EPS
-9.272373682
Actual EPS
N/A

Financials

-427.81%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
11.7MRevenue
-50.05MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AXDX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health, Inc. provides liquid biopsy tests that, like Accelerate Diagnostics, serve the diagnostics market with a focus on cancer, presenting a competitive edge in precision diagnostics.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products that compete with Accelerate Diagnostics in the women’s health diagnostic market.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. offers a range of products for the healthcare industry, including clinical diagnostics and life science research products that compete with Accelerate Diagnostics' offerings.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing across several segments with Accelerate Diagnostics.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates businesses in the environmental and applied solutions, life sciences, and diagnostics industries, competing with Accelerate Diagnostics in the diagnostics and research sectors.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. offers sample to insight solutions that transform biological materials into valuable molecular insights, competing in the diagnostics and research market similar to Accelerate Diagnostics.
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis, competing in the diagnostics and research market, particularly in genomics which is a growing area of diagnostics.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies, Inc. provides application-focused solutions in the life sciences, diagnostics, and applied chemical markets, directly competing with Accelerate Diagnostics in the diagnostics sector.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company offers a variety of medical devices and diagnostic products. While it has a broader focus, it competes with Accelerate Diagnostics in the diagnostics market, particularly in microbiology and infectious disease testing.

About

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Show more...
CEO
Mr. Jack Phillips
Employees
107
Country
US
ISIN
US00430H2013

Listings

0 Comments

Share your thoughts

FAQ

What is Accelerate Diagnostics stock price today?▼
The current price of AXDX is $0.03 USD — it has decreased by -61.36% in the past 24 hours. Watch Accelerate Diagnostics stock price performance more closely on the chart.
What is Accelerate Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Accelerate Diagnostics stocks are traded under the ticker AXDX.
Is Accelerate Diagnostics stock price growing?▼
AXDX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Accelerate Diagnostics has showed a -95.18% decrease.
What is Accelerate Diagnostics revenue for the last year?▼
Accelerate Diagnostics revenue for the last year amounts to 11.7M USD.
What is Accelerate Diagnostics net income for the last year?▼
AXDX net income for the last year is -50.05M USD.
How many employees does Accelerate Diagnostics have?▼
As of April 01, 2026, the company has 107 employees.
In which sector is Accelerate Diagnostics located?▼
Accelerate Diagnostics operates in the Health Care sector.
When did Accelerate Diagnostics complete a stock split?▼
The last stock split for Accelerate Diagnostics was on July 12, 2023 with a ratio of 1:10.
Where is Accelerate Diagnostics headquartered?▼
Accelerate Diagnostics is headquartered in Tucson, US.